Antimicrobial resistance (AMR) — the evolution of bacteria, viruses, fungi, and parasites that are no longer killed by drugs designed to treat them — is one of the greatest public health threats of the twenty-first century. Animal agriculture is a major driver of AMR globally, consuming approximately 73% of all antibiotics used worldwide. The connection between AMR and animal welfare is deep and structural: the conditions that necessitate prophylactic antibiotic use in agriculture are the same conditions that compromise animal welfare. Improving animal welfare and reducing AMR are fundamentally aligned goals.
Scale of the AMR crisis:
- ~1.27 million deaths annually directly attributable to AMR (2019 Lancet study) — more than HIV/AIDS or malaria
- Projected 10 million deaths per year by 2050 without action (O'Neill Review, 2016)
- 73% of global antibiotic use occurs in food-producing animals
- At least 30% of human AMR is estimated to derive from animal agriculture sources
- AMR costs the global economy an estimated $100 trillion by 2050 in the absence of effective action
Why Agriculture Uses So Many Antibiotics
Agricultural antibiotic use falls into three categories:
- Therapeutic: Treating sick individual animals — the only unambiguously justified use
- Metaphylactic: Treating entire groups when some individuals are sick — justified in some circumstances, problematic in others
- Prophylactic: Giving antibiotics to healthy animals to prevent future disease — the most AMR-relevant and welfare-revealing use
Prophylactic antibiotic use is driven almost entirely by intensive housing conditions that make disease outbreak inevitable without constant pharmaceutical prophylaxis. Animals crowded into barren, high-density environments without adequate ventilation, environmental enrichment, or immune-supporting conditions are disease-prone — and the industry response has historically been to dose them continuously with low-level antibiotics rather than address the underlying conditions.
The welfare-AMR nexus: This is the critical connection: the factory farming conditions that compromise welfare — high stocking density, barren environments, inadequate ventilation, chronic stress, inability to express natural behaviors — are precisely the conditions that drive the prophylactic antibiotic use fueling AMR. A welfare improvement that reduces crowding and stress also reduces the infection pressure that makes prophylactic antibiotics seem necessary.
Welfare Conditions That Drive AMR
Stocking Density
High stocking density increases pathogen transmission between animals, elevates stress hormones that suppress immune function, creates poor litter conditions (in poultry) and air quality problems, and reduces the ability of individual animals to avoid sick conspecifics. All of these factors increase disease incidence and the perceived need for antibiotic prophylaxis.
Barren Environments and Chronic Stress
Chronic stress — from barren housing, inability to perform natural behaviors, social conflict — elevates glucocorticoids that directly suppress immune function. Immunocompromised animals are more susceptible to infection and less able to recover from it without antibiotic support.
Early Weaning
Premature weaning of piglets (at 3–4 weeks instead of the natural 12–16 weeks) deprives them of maternal immunity transfer through milk, leaves them without the behavioral security of the dam relationship, and creates immune vulnerability that post-weaning prophylactic antibiotics are used to address.
Sweden as a Model: Welfare Improvement Reduces AMR
Sweden's 1986 ban on preventive antibiotic use — the first in the world — provides the strongest natural experiment for the welfare-AMR relationship. The industry predicted catastrophic losses. Instead:
- Swedish pig production survived and adapted through improved management, housing, and biosecurity
- Swedish antibiotic use in livestock fell dramatically
- Swedish AMR rates in food-producing animals remain among the lowest in Europe
- The adaptation required — better housing, larger weaning ages, improved management — were also welfare improvements
The policy convergence: Sweden demonstrates that reducing prophylactic antibiotic use and improving animal welfare are mutually reinforcing rather than competing goals. Countries that have reduced agricultural antibiotic use (Netherlands, Denmark, UK post-Brexit) have generally done so through combinations of regulatory restriction and welfare improvement — validating the structural connection between the two.
Regulatory Landscape
- EU: Regulation 2019/6 (effective January 2022) prohibits routine prophylactic antibiotic use and restricts metaphylactic use in EU livestock — a landmark reform covering the world's largest meat-importing market
- UK: Has reduced agricultural antibiotic use by 55% since 2014 through voluntary industry programs and regulatory pressure
- US: FDA Guidance 213 (2017) phased out growth-promotion use and required veterinary oversight for therapeutic antibiotics — significant but incomplete reform; routine prophylaxis still permitted under veterinary prescription
- China: Banned antibiotic growth promoters in 2020 — a major step given China's status as the world's largest agricultural antibiotic user
Alternatives to Prophylactic Antibiotics
The transition away from prophylactic use requires alternative approaches:
- Improved housing: Reducing stocking density, improving ventilation, providing enrichment — addressing the welfare conditions that drive disease
- Vaccination: More comprehensive vaccination programs can reduce therapeutic as well as prophylactic antibiotic needs
- Probiotics and prebiotics: Emerging evidence for gut microbiome support as an alternative to antibiotic growth promotion
- Biosecurity: All-in/all-out stocking, cleaning and disinfection protocols, controlled access
- Phages: Bacteriophage therapy as a targeted alternative to broad-spectrum antibiotics
- Genetic selection: Breeding for disease resistance alongside production traits
One Health: The Integrated Framework
The "One Health" framework — recognizing that human health, animal health, and environmental health are inextricably interconnected — provides the most powerful framework for addressing AMR. Antibiotic resistance genes in animal agriculture transfer to human pathogens through direct contact, food, water, and environmental pathways. Reducing AMR in animals is inseparable from reducing AMR in humans.
The strategic alignment: AMR provides animal welfare advocates with one of the strongest allies they could ask for: the public health community. When welfare advocates argue for reduced stocking density, earlier weaning improvements, and better housing conditions in agriculture, they are simultaneously arguing for AMR reduction. This alignment creates coalition-building opportunities that can advance welfare goals through public health channels — reaching policymakers, funders, and publics that may not be primarily motivated by animal welfare but are deeply concerned about AMR.
Conclusion
The connection between antimicrobial resistance and animal welfare is structural, not incidental. The same intensive conditions that compromise animal welfare create the disease burden that drives prophylactic antibiotic use. Improving welfare reduces that disease burden, making antibiotic stewardship more achievable. The policy convergence between AMR reduction and welfare improvement is one of the most important strategic opportunities available to the animal welfare movement — and one that deserves far more attention than it currently receives.